Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats
Authors:
Open Access
- 28 June 2008
- journal article
- research article
- Published by Wiley in Experimental Physiology
- Vol. 93 (7) , 817-824
Abstract
Recently, we reported the presence of a local renal aldosterone production. In the present study, we tested the hypothesis that local aldosterone production in the kidney contributes to renal inflammation, matrix formation and albuminuria associated with diabetes. We evaluated changes in renal aldosterone content (RAC), aldosterone synthase expression, nuclear factor κB (NFκB), tumour necrosis factor α (TNFα), interleukin‐6 (IL‐6), transforming growth factor β (TGFβ), glomerular fibronectin, collagen type IV and urinary albumin extraction (UAE) in response to the aldosterone synthase inhibitor FAD286. Studies were conducted in adrenalectomized, normoglycaemic (control) or diabetic rats for 14 weeks. The FAD286 was administered during the last 10 weeks of the study. Plasma aldosterone levels were not detectable in any of the study groups. Compared with control rats, diabetic rats had higher levels of RAC by 488% (P < 0.01), NFκB by 293% (P < 0.01), TNFα by 356% (P < 0.01), IL‐6 by 378% (P < 0.01), TGFβ by 337% (P < 0.01) and UAE by 1122% (P < 0.01), and increased glomerular fibronectin and collagen type IV immunostaining. In diabetic rats, FAD286 reduced RAC (P < 0.01), UAE (P < 0.05), NFκB mRNA, TNFα mRNA, IL‐6 mRNA and TGFβ mRNA by 51, 41, 41 and 52% and also their proteins and decreased glomerular fibronectin and collagen type IV immunostaining. In conclusion, diabetes increases local aldosterone production in the kidney, which contributes to development of renal inflammation, matrix formation and albuminuria. Inhibition of aldosterone production in the kidney could be helpful in management of diabetic nephropathy.Keywords
This publication has 33 references indexed in Scilit:
- Local Renal Aldosterone System and Its Regulation by Salt, Diabetes, and Angiotensin II Type 1 ReceptorHypertension, 2005
- Involvement of Aldosterone and Mineralocorticoid Receptors in Rat Mesangial Cell Proliferation and DeformabilityHypertension, 2005
- Is aldosterone synthesized within the rat brain?American Journal of Physiology-Endocrinology and Metabolism, 2005
- Spironolactone prevents early renal injury in streptozotocin-induced diabetic ratsKidney International, 2004
- Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin‐diabetic ratsBritish Journal of Pharmacology, 2001
- Vascular Aldosterone in Genetically Hypertensive RatsHypertension, 1997
- Reduced Plasma Aldosterone Concentrations in Randomly Selected Patients with Insulin‐dependent Diabetes MellitusDiabetic Medicine, 1995
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Structural-functional relationships in diabetic nephropathy.Journal of Clinical Investigation, 1984